How Long Does HPV Last? Timeline From Infection

In most people, HPV lasts under two years and clears on its own; about 9 out of 10 infections disappear within that window without causing any health problems CDC. An infection that persists past roughly two years is the one that matters, because lasting high-risk HPV can slowly progress toward precancer and cancer.

The essentials: clearance, persistence, and what the timeline really means

HPV is the most common sexually transmitted infection, and for most people it behaves more like a passing cold than a permanent condition. Your immune system recognizes the virus and suppresses or eliminates it, usually within about two years. During that time you typically feel nothing. Most HPV infections are asymptomatic and never produce a single visible sign.

What drives cancer risk is how long a high-risk type sticks around. When the same cancer-causing type keeps showing up year after year, it has time to push cervical, anal, or throat cells through gradual precancerous changes. Guidance focuses on persistence rather than a one-time positive result.

It helps to separate two things people constantly blur together. Low-risk types (mainly 6 and 11) cause genital warts; high-risk types (16, 18, and several others) cause cancers, and the wart types do not cause cancer CDC Pink Book. A wart, while annoying, isn't a cancer warning, and a high-risk infection usually causes no bump at all.

There's no test that tells you the exact day you were infected, so the "timeline" is biological rather than a stopwatch: exposure, a usually-silent infection, then either clearance within roughly two years or persistence. If you're trying to pin down exposure timing for any STI, see our guide on when to test after exposure.

Symptoms: what (if anything) you'll notice

High-risk HPV usually causes nothing. Most infections are silent and produce no clinical disease, so screening is how cancer-causing HPV gets caught. You can carry, transmit, and clear high-risk HPV without ever knowing it was there.

Low-risk types announce themselves differently. Genital warts usually appear as a small bump or a group of bumps in the genital area; they can be flat or raised, single or clustered, and are generally painless. Their presence means you picked up a wart-causing type, not a cancer-causing one. For a fuller look at how warts present and behave, see hpv & genital warts.

HPV's cancer toll reaches well beyond the cervix. It causes virtually all cervical cancer, over 90% of anal cancers, and about 70% of throat (oropharyngeal) cancers NCI. Oropharyngeal cancer has now overtaken cervical cancer as the most common HPV-related cancer in the US. These cancers develop slowly and silently over years of persistent infection, so a single positive test isn't a diagnosis of anything.

Testing: how persistence is actually detected

You can't feel persistence, so it's measured indirectly through cervical screening. Current guidance starts cervical screening at age 25 with a primary HPV test every 5 years, the preferred approach, rather than a yearly Pap American Cancer Society. The longer interval works because most HPV clears within two years. Testing too often just catches infections that would have vanished anyway, while the HPV test itself finds more true precancer with fewer visits.

Repeat screening flags persistence. If a high-risk type keeps turning up across screening cycles, a clinician acts on that signal, moving toward closer follow-up or a look at the cervix for cervical cancer and cervical dysplasia. A single positive followed by a clear result later usually means your body did its job.

A few testing realities surprise people. There's no routine HPV test for men, and HPV tests aren't recommended to screen men, adolescents, or women under age 30. For women, high-risk HPV is found through cervical screening, not a general STD panel, so a standard panel won't tell you your HPV status. HPV testing also isn't used to diagnose warts; results don't confirm or guide wart management, which is a clinical (visual) diagnosis. As for anal screening, CDC's 2021 guidance found data insufficient to recommend routine anal cytology, even for men who have sex with men or people with HIV; the 2022 ANCHOR trial later showed that treating high-grade anal lesions reduced anal cancer in people with HIV, and some specialty groups (e.g., IDSA/HIVMA) now suggest periodic anal Pap for high-risk groups where high-resolution anoscopy referral exists, though it's not a blanket CDC recommendation. If you want screening, you can get tested.

Treatment: you treat the problems, not the virus

There's no drug that cures HPV itself. Your immune system clears the virus; treatment targets what the virus causes, warts and cancer precursors, which are managed completely separately.

For genital warts, you have two practical routes. At home, you can apply a prescription patient-applied treatment such as imiquimod 3.75% or 5% cream, podofilox 0.5% solution or gel, or sinecatechins 15% ointment (sinecatechins aren't recommended for people who are immunocompromised or HIV-positive) CDC STI Treatment Guidelines. In the clinic, a provider can use cryotherapy (freezing with liquid nitrogen or a cryoprobe), TCA or BCA 80%–90% solution, or surgical removal by excision, curettage, laser, or electrosurgery.

In practice, a clinic freezes the warts or you dab on a cream over several weeks, and no single method is clearly best. Clearing the visible warts doesn't remove the virus, so warts can recur after treatment. That's normal, not a treatment failure. Cancer precursors are a different track entirely: they're found and managed through screening and follow-up, never through wart creams.

Prevention: the vaccine, screening, and condoms

Vaccination is the strongest lever. The HPV vaccine used in the US today is Gardasil 9, which protects against nine types — 6, 11, 16, 18, 31, 33, 45, 52, and 58 American Cancer Society. Given at the recommended ages, it can prevent more than 90% of HPV-caused cancers, and it's about 98% effective against the precancers caused by HPV 16 and 18. For context, types 16 and 18 cause about 66% of cervical cancers, the five added high-risk types (31, 33, 45, 52, 58) cause roughly another 15%, and types 6 and 11 cause more than 90% of genital warts.

The shot can't fix an infection you already have. Gardasil 9 protects against future infection but won't clear HPV or warts you've already got, and vaccinated people still need cervical screening. The older shots covered fewer types: the earlier quadrivalent Gardasil covered 6, 11, 16, and 18, and bivalent Cervarix covered 16 and 18. Since 2016 only Gardasil 9 has been distributed in the US, so it guards against more cancer-causing types than the older versions.

Condoms give partial protection because HPV can infect areas a condom doesn't cover, so they lower but don't eliminate risk. For more on that gap, see can you get hpv while using condoms?.

When to see a clinician

• You notice new bumps in the genital, anal, or oral area and want them evaluated and, if you choose, treated.
• You're due for cervical screening (generally from age 25) or your last result flagged a high-risk type that needs follow-up.
• A high-risk HPV type keeps showing up across screening cycles, and that persistence triggers closer monitoring.
• You haven't been vaccinated and want to discuss whether Gardasil 9 makes sense for you.
• You have HIV or are immunocompromised and want to talk through screening options, including anal screening where appropriate.